Investigation towards bivalent chemically defined glycoconjugate immunogens prepared from acid-detoxified lipopolysaccharide of Vibrio cholerae O1, serotype Inaba

Glycoconjugate Journal

Volumn 26, Issue 1, 2009, Pages 41-55

  Grandjean, Cyrille ^a,b   Boutonnier, Alain ^a   Dassy, Bruno ^a   Fournier, Jean Michel ^a   Mulard, Laurence A ^a  

^a INSTITUT PASTEUR   (France)

^b UNIVERSITÉ DE PICARDIE JULES VERNE   (France)

Author keywords

Cholera vaccine; Lipopolysaccharide; Neoglycoconjugate; Vibrio cholerae O1

Indexed keywords

GLYCOCONJUGATE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LIPOPOLYSACCHARIDE;

ARTICLE; B LYMPHOCYTE; BIOTINYLATION; CONJUGATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOGENICITY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SEROTYPE; T LYMPHOCYTE; VIBRIO CHOLERAE;

ANIMALS; ANTIBODIES, BACTERIAL; CHOLERA VACCINES; FEMALE; IMMUNITY, CELLULAR; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED BALB C; SPECIES SPECIFICITY; T-LYMPHOCYTES; VACCINES, SYNTHETIC; VIBRIO CHOLERAE O1;

MUS; VIBRIO CHOLERAE;

EID: 59449092176     PISSN: 02820080     EISSN: 15734986     Source Type: Journal    
DOI: 10.1007/s10719-008-9160-6     Document Type: Article

References (77)

1. WHO Meeting: Cholera vaccines: a new public health tool?, pp. 10-11. Geneva, Switzerland (2002), December
2. E.T. Ryan S.B. Calderwood F. Qadri 2006 Live attenuated oral cholera vaccines Expert Rev. Vaccines 5 483 494
3. J.N. Zuckerman L. Rombo A. Fish 2007 The true burden and risk of cholera: implications for prevention and control Lancet Infect. Dis. 7 521 530
4. C.L. Chaignat V. Monti 2007 Use of oral cholera vaccine in complex emergencies: what next? Summary report of an expert meeting and recommendations of WHO J. Health Popul. Nutr. 25 244 261
5. S. Kabir 2005 Cholera vaccines: the current status and problems Rev. Med. Microb. 16 101 116
6. D. Provenzano P. Kovac W.F. Wade 2006 The ABCs (antibody, B cells, and carbohydrate epitopes) of cholera immunity: considerations for an improved vaccine Microbiol. Immunol. 50 899 207
7. D.A. Sack R.B. Sack G.B. Nair A.K. Siddique 2004 Cholera Lancet 363 223 233
8. A.A. Lindberg 1999 Polyosides (encapsulated bacteria) C. R. Acad. Sci. III 322 925 932
9. D. Goldblatt 2000 Conjugate vaccines Clin. Exp. Immunol. 119 1 3
10. W.M. McCormack J. Chakraborty A.S. Rahman W.H. Mosley 1969 Vibriocidal antibody in clinical cholera J. Infect. Dis. 120 192 201
11. J.B. Robbins R. Schneerson S.C. Szu 1997
12. F. Qadri G. Mohi J. Hossain T. Azimi A.M. Khan M.A. Salam R.B. Sack M.J. Albert A.M. Svennerholm 1995 Comparison of vibriocidal antibody response in cholera due to Vibrio cholerae O139 Bengal with the response in cholera due to Vibrio cholerae O1 Clin. Diagn. Lab. Immunol. 2 685 688
13. F. Qadri C. Wenneras M.J. Albert J. Hossain K. Mannoor Y.A. Begum 1997 Comparison of immune responses in patients infected with Vibrio cholerae O139 and O1 Infect. Immun. 65 3571 3576
14. A. Boutonnier S. Villeneuve F. Nato B. Dassy J.-M. Fournier 2001 Preparation, immunogenicity, and protective efficacy, in a murine model, of a conjugate vaccine composed of the polysaccharide moiety of the lipopolysaccharide of Vibrio cholerae O139 bound to tetanus toxoid Infect. Immun. 69 3488 3493
15. J.A. Johnson A. Joseph J.G. Morris Jr. 1995 Capsular polysaccharide- protein conjugate vaccines against Vibrio cholerae O139 Bengal Bull. Inst. Pasteur 93 285 290
16. S. Kossaczka J. Shiloach V. Johnson D.N. Taylor R.A. Finkelstein J.B. Robbins 2000 Vibrio cholerae O139 conjugate vaccines: synthesis and immunogenicity of V. cholerae O139 capsular polysaccharide conjugates with recombinant diphteria toxin mutant in mice Infect. Immun. 68 5037 5043
17. S. Kossaczka S.C. Szu 2000 Effect of synthetic schemes to prepare immunogenic conjugates of Vibrio cholerae O139 capsular polysaccharide with chicken serum albumin Glycoconj. J. 17 425 433
18. A. Chernyak S. Kondo T.K. Wade M.D. Meeks P.M. Alzari J.-M. Fournier 2002 Induction of protective immunity by synthetic Vibrio cholerae hexasaccharide derived from V. cholerae O1 Ogawa lipolysaccharide bound to a protein carrier J. Infect. Dis. 185 950 962
19. R. Saksena X. Ma T.K. Wade P. Kovàç W.F. Wade 2005 Effect of saccharide length on the immunogenicity of neoglycoconjugates from synthetic fragments of the O-SP of Vibrio cholerae O1, serotype Ogawa Carbohydr. Res. 340 2256 2269
20. M.D. Meeks R. Saksena X. Ma T.K. Wade R.K. Taylor P. Kovàç 2004 Synthetic fragments of Vibrio cholerae O1 Inaba O-SP bound to a protein carrier are immunogenic in mice but do not induce protective antibodies Infect. Immun. 72 4090 4101
21. L.B. Adams R.J. Siebeling 1984 Production of Vibrio cholerae O1 and non-O1 typing sera in rabbits immunized with polysaccharide-protein carrier conjugates J. Clin. Microbiol. 19 181 186
22. S. Kabir 1987 Preparation and immunogenicity of a bivalent cell-surface protein-polysaccharide conjugate of Vibrio cholerae. J Med. Microbiol. 23 9 18
23. R.K. Gupta S.C. Szu R.A. Finkelstein J.B. Robbins 1992 Synthesis, characterization, and some immunological properties of conjugates composed of the detoxified lipopolysaccharide of Vibrio cholerae O1 serotype Inaba bound to cholera toxin Infect. Immun. 60 3201 3208
24. E. Paulovicoca E. Machova A. Hostacka S. Bystricky 2006 Immunological properties of complex conjugates based on Vibrio cholerae O1 Ogawa lipopolysaccharide antigen Clin. Exp. Med. 144 521 527
25. O. Cabrera M.E. Martinez M. Cuello C.R. Soto T. Valmaseda B. Cedré G. Sierra Gonzalez 2006 Preparation and evaluation of Vibrio cholerae O1 El Tor Ogawa lipopolysaccharide-tetanus toxoid conjugates Vaccine 24S2 S2/74 S2/75
26. R.K. Gupta D.N. Taylor D.A. Bryla J.B. Robbins S.C. Szu 1998 Phase 1 evaluation of Vibrio cholerae O1 serotype Inaba, polysaccharide-cholera toxin conjugates in adult volonteers Infect. Immun. 66 3095 3099
27. R. Saksena X. Ma T.K. Wade P. Kovac W.F. Wade 2006 Length of the linker and the interval between immunizations influences the efficacy of Vibrio cholerae O1, Ogawa hexasaccharide neoglycoconjugates FEMS Immunol. Med. Microbiol. 47 116 128
28. A. Fattom X. Li Y.H. Cho A. Burns A. Hawwari S.E. Shepherd 1995 Effect of conjugation methodology, carrier protein, and adjuvants on the immune response to Staphylococcus aureus capsular polysaccharides Vaccine 13 1288 1293
29. V. Pozsgay C. Chu L. Pannell J. Wolfe J.B. Robbins R. Schneerson 1999 Protein conjugates of synthetic saccharides elicit higher levels of serum IgG lipopolysaccharide antibodies in mice than do those of the O-specific polysaccharide from Shigella dysenteriae type 1 Proc. Natl. Acad. Sci. U S A 96 5194 5197
30. S.N. Chatterjee K. Chaudhuri 2003 Lipopolysaccharides of Vibrio cholerae I. Physical and chemical characterization Biochim. Biophys. Acta 1639 65 79
31. F. Bougoudogo F. Vély F. Nato A. Boutonnier P. Gounon J.-C. Mazie 1995 Protective activities of serum immunoglobulin G on the mucosal surface to Vibrio cholerae O1 Bull. Inst. Pasteur 93 273 283
32. F. Ahmed G. André-Leroux A. Haouz A. Boutonnier M. Delepierre F. Qadri 2007 Crystal structure of a monoclonal antibody directed against an antigenic determinant common to Ogawa and Inaba serotypes of Vibrio cholerae O1 Proteins 70 284 288
33. J. Wang S. Villeneuve J. Zhang P. Lei C.E. Miller P. Lafaye 1998 On the antigenic determinants of the lipopolysaccharides of Vibrio cholerae O:1, serotypes Ogawa and Inaba J. Biol. Chem. 273 2777 2783
34. O. Wesphal K. Jann 1965 Bacterial lipopolysaccharides, extraction with phenol-water and further applications of the procedure Methods Carbohydr. Chem. 5 83 91
35. Sambrook, J., Fritsch, E.F., Maniatis, T.: Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory, New York (1989)
36. D. Herbert P.J. Phipps R.E. Strange 1971 Chemical analysis of microbial cells Methods Microbiol. 5B 209 344
37. O.H. Lowry N.J. Rosebrough A.L. Farr R.J. Randall 1951 Protein measurement with the Folin phenol reagent J. Biol. Chem. 193 265 275
38. Johnstone, A., Thorpe, R.: Immunochemistry in Practice. Blackwell Scientific, Oxford (1982)
39. Plikaytis, B.D., Holder, P.F., Carlone, G.M.: Program ELISA for Windows user's manual version 1.00. Centers for Disease Control and Prevention, Atlanta, Ga (1996)
40. A. Boutonnier B. Dassy R. Duménil A. Guénolé M. Ratsitorahina R. Migliani 2003 A simple and convenient microtiter plate assay for the detection of bactericidal antibodies to Vibrio cholerae O1 and Vibrio cholerae O139 J. Microbiol. Methods 55 745 753
41. E.V. Vinogradov K. Bock O. Holst H. Brade 1995 The structure of the lipid A-core region of the lipopolysaccharides from V. cholerae O1 smooth strain 569B (Inaba) and rough mutant strain 95R (Ogawa) Eur. J. Biochem. 233 152 158
42. L. Kenne B. Lindberg P. Unger B. Gustafsson T. Holme 1982 Structural studies of the Vibrio cholerae O-antigen Carbohydr. Res. 100 341 349
43. K. Hisatsune M. Hayashi Y. Haishima S. Kondo 1989 Relationship between structure and antigenicity of O1 Vibrio cholerae lipopolysaccharides J. Gen. Microbiol. 135 1901 1907
44. W.A. Volk N.L. Salomonsky D. Hunt 1972 Xanthomonas sinensis cell wall lipopolysaccharide J. Biol. Chem. 247 3881 3887
45. F.-I. Auzanneau D. Charon L. Szabó 1991 Phosphorylated sugars. Part 27. Synthesis and reactions, in acid medium, of 5-O-substituted methyl 3-deoxy-α-D-manno-oct-2-ulopyranosidonic acid 4-phosphates J. Chem. Soc., Perkin Trans. 1 509 517
46. S. Villeneuve A. Boutonnier L.A. Mulard J.-M. Fournier 1999 Immunochemical characterization of an Ogawa-Inaba common antigenic determinant of Vibrio cholerae O1 Microbiology 145 2477 2484
47. V. Pozsgay 2000 Oligosaccharide-protein conjugates as vaccine candidates against bacteria Adv. Carbohydr. Chem. Biochem. 56 153 199
48. K. Wright C. Guerreiro I. Laurent F. Baleux L.A. Mulard 2004 Preparation of synthetic glycoconjugates as potential vaccines against Shigella flexneri serotype 2a disease Org. Biomol. Chem. 2 1518 1527
49. C.J.M. Stroop Q. Xu M. Retzlaff C. Abeygunawardana C.A. Bush 2002 Structural analysis and chemical depolymerization of the capsular polysaccharide of Streptococcus pneumoniae type 1 Carbohydr. Res. 337 335 344
50. L. Kenne B. Lindberg V. Petersson E. Katzenellenbogen E. Romanowska 1980 Structural studies of the O-specific side chains of the Shigella sonnei phase I lipopolysaccharide Carbohydr. Res. 78 119 126
51. C. Jones 2005 Vaccines based on the cell surface carbohydrates of pathogenic bacteria An. Acad. Bras. Cienc. 77 293 324
52. O. Cabrera M. Cuello C.R. Soto M.E. Martinez J.M. del Campo O. Pérez J.F. Infante G. Sierra 2006 New method for obtaining conjugated vaccines Vaccine 24S2 S2/76 S2/78
53. C.A. Laferrière R.H. Sood J.M. de Muys F. Michon H.J. Jennings 1998 Streptococcus pneumoniae type 14 polysaccharide-conjugate vaccines: length stabilization of opsonophagocytic conformational polysaccharide epitopes Infect. Immun. 66 2441 2446
54. P.J. Meikle N.M. Young D.R. Bundle 1990 O-antigen biotin conjugate. Preparation and use in direct competitive enzyme immunoassays J. Immunol. Methods 132 255 261
55. A. Sutton W.F. Vann A.B. Karpas K.E. Stein R. Schneerson 1985 An avidin-biotin based ELISA for quantitation of antibody to bacterial polysaccharides J. Immunol. Methods 82 215 224
56. A.F.M. Verheul A.A. Versteeg N.A.C. Westerdaal G.J. Van Dam M. Jansze H. Snippe 1990 Measurement of the humoral immune response against Streptococcus pneumoniae type 14-derived antigen by an ELISA and ELISPOT assay based on biotin-avidin technology J. Immunol. Methods 126 79 87
57. J.M. Peeters T.G. Hazendonk E.C. Beuvery G.I. Tesser 1989 Comparison of four bifunctional reagents for coupling peptides to proteins and the effect of the three moieties on the immunogenicity of the conjugates J. Immunol. Methods 120 133 143
58. -) lipopolysaccharide preparations: Identification of novel core oligosaccharide components and three 3-deoxy-D-manno-oct-2- ulopyranosic artifacts J. Mass Spectrom. 34 622 636
59. A. Dell P. Azadi P. Tiller J. Thomas-Oates H.J. Jennings M. Beurret 1990 Analysis of oligosaccharide epitopes of meningococcal lipopolysaccharides by fast-atom-bombardment mass spectroscopy Carbohydr. Res. 200 59 76
60. S. Villeneuve H. Souchon M.-M. Riottot J.-C. Mazié P. Lei C.P.J. Glaudemans P. Kovác J.-M. Fournier P.M. Alzari 2000 Crystal structure of an anti-carbohydrate antibody directed against Vibrio cholerae O1 in complex with antigen: molecular basis for serotype specificity Proc. Natl. Acad. Sci. U S A 97 8433 8438
61. Hermanson, G.T.: Bioconjugate Techniques. Academic, San Diego (1995)
62. A. Chernyak A. Karavanov Y. Ogawa P. Kovac 2001 Conjugating oligosaccharides to proteins by squaric acid diester chemistry: rapid monitoring of the progress of conjugation, and recovery of the unused ligand Carbohydr. Res. 330 479 486
63. W.H. Mosley W.E. Woodward K.M.A. Aziz A.S.M. Mizanur Rahman A.K.M. Alauddin Chowdhury A. Ahmed 1970 The 1968-1969 cholera-vaccine field trial in rural East Pakistan. Effectiveness of monovalent Ogawa and Inaba vaccines and a purified Inaba antigen, with comparative results of serological and animal protection tests J. Infect. Dis. 121 S1 S9
64. W.H. Mosley K.M.A. Aziz A.S.M. Mizanur Rahman A.K.M. Alauddin Chowdhury A. Ahmed 1973 Field trials of monovalent Ogawa and Inaba cholera vaccines in rural Bangladesh-three years of observation Bull. World Health Organ. 49 381 387
65. M.L. Levine N.F. Pierce 1992
66. H. Brade C. Galanos 1983 A new lipopolysaccharide antigen identified in Acinetobacter calcoaceticus: occurrence of widespread natural antibody J. Med. Microbiol. 16 203 210
67. H. Brade C. Galanos 1983 Common lipopolysaccharide specificity: new type of antigen residing in the inner core region of S- and R-form lipopolysaccharides from different families of gram-negative bacteria Infect. Immun. 42 250 256
68. C. Boeckler B. Frisch S. Muller F. Schuber 1996 Immunogenicity of new heterobifunctional cross-linking reagents used in the conjugation of synthetic peptides to liposomes J. Immunol. Methods 191 1 10
69. y may be suppressed by a bifunctional cross-linker required for coupling to a carrier protein Chem. Eur. J. 10 3517 3524
70. V. Verez-Bencomo V. Fernández-Santana E. Hardy M.E. Toledo M.C. Rodríguez L. Heynngnezz 2004 A synthetic conjugate polysaccharide vaccine against Haemophilus influenzae type b Science 305 522 525
71. E.C. Beuvery R.W. van Delft F. Miedema V. Kanhai J. Nagel 1983 Immunological evaluation of meningococcal group C polysaccharide-tetanus toxoid conjugate in mice Infect. Immun. 41 609 617
72. H. Braley-Mullen 1980 Direct demonstration of specific suppressor T cells in the mice tolerant to type III pneumococcal polysaccharide: two-step requirement for development of detectable suppressor cells Immunology 40 521 527
73. D. Wilson H. Braley-Mullen 1981 Antigen requirements for priming of type III pneumococcal polysaccharide-specific IgG memory responses: suppression of memory with the T-independent form of antigen Cell. Immunol. 64 177 186
74. C.C.A.M. Peeters A.-M.J. Tenbergen-Meekes J.T. Poolman B.J.M. Zegers G.T. Rijkers 1992 Immunogenicity of a Streptococcus pneumoniae type 4 polysaccharide-protein conjugate vaccine is decreased by admixture of high doses of free saccharide Vaccine 10 833 840
75. M.E. Rodriguez G.P.J.M. van den Dobbelsteen L.A. Oomen O. de Weers L. van Buren M. Beurret 1998 Immunogenicity of Streptococcus pneumoniae type 6B and 14 polysaccharide-tetanus toxoid conjugates and the effect of uncoupled polysaccharide on the antigen-specific immune response Vaccine 16 1941 1949
76. T. Wuorimaa H. Kaythy O. Leroy J. Eskola 2001 Tolerability and immunogenicity of an 11-valent pneumoccocal conjugate vaccine in adults Vaccine 19 1863 1869
77. 197 conjugate vaccine occurs despite vigorous T cell help induced by the catrrier protein J. Infect. Dis. 187 1629 1638